Latest stories on BAYRY
Bayer Completes Key Sevabertinib–Metformin Study, Bolstering Pipeline Confidence
TipRanks63 · neutralproduct/pr
Bayer Gets China Approval for Stroke-Prevention Drug in Global First for New Class — Update
Morningstar74 · bullishproduct/pr
Why is Bayer stock rallying today?
Investing.com Markets62 · neutralgeneral
Bayer Wins China Approval for Potential Blockbuster Stroke Drug
Bloomberg78 · bullishproduct/pr
Bayer announces new data at ESMO 2026 on NUBEQA
The Fly58 · neutralproduct/pr
Bayer Expands Real-World Kidney Data For Finerenone, Eyeing Long-Term Upside For BAYRY
TipRanks58 · neutralproduct/pr
Bayer: Turnaround Is Gaining Momentum, But Debt Remains A Risk
Seeking Alpha58 · neutralgeneral
Bayer announces FDA acceptance of Kerendia sNDA
The Fly64 · neutralproduct/pr
FDA accepts Bayer’s Kerendia filing for kidney disease without diabetes
Investing.com Markets64 · neutralproduct/pr
Bayer Plans $2.2 Billion US Drug Plant Against Tariff Backdrop
Bloomberg58 · neutralgeneral
Bayer to relaunch Alka-Seltzer Plus as Alka-Seltzer Cold in 2026
The Fly55 · neutralproduct/pr
Bayer announces FDA accepts Lynkuet sNDA for Priority Review
The Fly63 · neutralproduct/pr
Bayer to sell cancer drug Stigvarga for up to $431M, WSJ reports
The Fly54 · neutralm&a
Bayer Sells Cancer Drug to Gruenenthal for Up to $431 Million
WSJ Business54 · neutralm&a
Bayer’s Monsanto unit urges Missouri judge to approve $7.25 billion Roundup settlement
Investing.com Markets48 · neutralgeneral
Bayer faces pivotal test of $7.25 billion Roundup settlement in Missouri court
Reuters38 · neutralgeneral
Bayer faces pivotal test of $7.25 billion Roundup settlement in Missouri court
Yahoo Finance48 · neutralgeneral
Bayer Expands Real World Surveillance for Darolutamide in Indian Prostate Cancer Market
TipRanks56 · neutralproduct/pr
Bayer granted accelerated approval for Hyrnuo by FDA
The Fly73 · bullishproduct/pr